Neochem Bio Solutions
add_icon

Neochem Bio Solutions

96.00
-3.55
(-3.57%)
Market Cap
164.36 Cr
PE Ratio
21.98
Volume
2,400.00
Day High - Low
99.55 - 96.00
52W High-Low
121.00 - 63.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
164.36 Cr
EPS
6.64
PE Ratio
21.98
PB Ratio
2.38
Book Value
41.89
EBITDA
15.10
Dividend Yield
0.00 %
Industry
Chemicals
Return on Equity
39.24
Debt to Equity
2.17
Forecast For
Actual

Company News

View All News
Caret
positive
Promoter Swapnil Rameshbhai Makati purchased 6,000 equity shares of Neochem Bio Solutions on July 28, 2026, raising his stake from 54.67% to 54.70%.
positive
Neochem Bio Solutions Limited reported a 32% rise in FY26 revenue to INR110.7 crore. PAT grew 62% to INR12 crore with EBITDA margins expanding to 20.4%.
positive
Neochem Bio Solutions reported a 62% YoY rise in PAT to ₹1,203 lakh for FY26. Revenue grew 32% to ₹11,069 lakh.
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,649.00
#1 1,67,831.15
63.22
14,867.00
11.05
#1 2,471
30.29
51.87
2,571.90
76,237.50
35.25
#1 15,893.60
7.20
1,835
75.55
38.89
4,621.90
50,771.57
85.66
4,996.00
2.94
569
20.33
58.55
8,206.50
42,079.17
53.60
3,379.20
#1 41.21
664
107.59
56.99
654.40
33,017.20
44.14
4,832.00
3.60
755
27.31
31.89
1,747.10
23,829.23
30.47
7,946.90
-5.01
551
207.21
54.40
1,626.60
21,587.03
92.24
1,160.14
31.79
240
33.62
64.02
6,509.50
19,165.11
#1 23.67
6,476.40
13.77
689
91.77
42.50
527.20
19,115.98
35.62
8,286.00
13.73
365
#1 260.47
61.60
3,902.70
16,893.09
25.97
15,009.80
1.01
416
162.23
51.46

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
39.03 %
Net Income Growth
333.33 %
Cash Flow Change
32.14 %
ROE
161.43 %
ROCE
117.68 %
EBITDA Margin (Avg.)
58.55 %

Yearly Financial Results

Annual Financials
2024
2025
TTM
Revenue
62
86
0
Expenses
55
71
0
EBITDA
7
15
0
Operating Profit %
10 %
16 %
0 %
Depreciation
1
1
0
Interest
3
4
0
Profit Before Tax
3
10
0
Tax
1
3
0
Net Profit
2
8
0
EPS in ₹
1.90
6.64
0.00

Balance Sheet

Balance Sheet
2024
2025
Total Assets
64
79
Fixed Assets
19
19
Current Assets
39
53
Capital Work in Progress
0
0
Investments
0
0
Other Assets
45
60
Total Equity & Liabilities
64
79
Current Liabilities
33
44
Non Current Liabilities
19
15
Total Equity
12
20
Reserve & Surplus
5
13
Share Capital
7
7

Cash Flow

Cash Flow
2023
2024
2025
Net Cash Flow
-0
0
-0
Investing Activities
-3
-8
-2
Operating Activities
-1
2
3
Financing Activities
4
6
-1

Share Holding

% Holding
Aug 2025
Nov 2025
Dec 2025
Mar 2026
Promoter
91.12 %
91.12 %
91.12 %
66.72 %
FIIs
0.00 %
0.00 %
0.00 %
0.18 %
DIIs
0.00 %
0.00 %
0.00 %
15.82 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
0.00 %
10.93 %
Others
8.88 %
8.88 %
8.88 %
6.35 %
No of Share Holders
14
14
14
406

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 May 2026 86.60 93.60

Technical Indicators

RSI(14)
Neutral
55.37
ATR(14)
Volatile
3.20
STOCH(9,6)
Overbought
84.58
STOCH RSI(14)
Overbought
84.71
MACD(12,26)
Bullish
1.02
ADX(14)
Weak Trend
14.97
UO(9)
Bearish
60.85
ROC(12)
Uptrend And Accelerating
5.79
WillR(14)
Neutral
-31.01